{"id":"phethenylate","rwe":[],"tags":[{"label":"phethenylate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"thiantoin","offLabel":[],"synonyms":["phethenylate","thiantoin","thiantoine","thyphenytoin","tiantoina","phethenylate sodium","thiatoine sodium"],"timeline":[],"approvals":[],"brandName":"Thiantoin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"phethenylate","explanation":"Imagine your body's cells have locks on them, and Thiantoin has a key that fits into one of those locks. When it binds to the lock, it triggers a series of events that help to treat a particular condition. This is a simplified explanation of how Thiantoin works at a molecular level.","oneSentence":"Thiantoin works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Thiantoin's mechanism of action involves binding to a specific protein or receptor, which triggers a cascade of downstream effects that ultimately lead to its therapeutic effects. The exact details of this process are not well understood without more information on its target and pharmacology."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3816","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=phethenylate","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:19:35.904810","biosimilars":[],"competitors":[],"genericName":"phethenylate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"V1989D4JPB","CHEBI":"CHEBI:135065","PUBCHEM_CID":"31325"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":7,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Thiantoin (phethenylate) is a small molecule drug of the phethenylate class, but information on its target, FDA approval status, and approved indications is currently unavailable. As a result, its commercial status, half-life, bioavailability, and generic manufacturers are also unknown. Further research is needed to determine the efficacy and safety of Thiantoin in treating specific conditions. Key safety considerations cannot be assessed without more information on its pharmacology and clinical trials. A comprehensive understanding of Thiantoin's properties and uses requires additional data.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}